Skip to content

Alcon Multi-Purpose Disinfecting Solution Versus Renu Fresh Multi-Purpose Solution in Symptomatic Contact Lens Wearers

SiH MPDS FID 114675A Compared to Renu Fresh MPS in Symptomatic Contact Lens Wearers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01187355
Enrollment
591
Registered
2010-08-24
Start date
2010-07-31
Completion date
2011-01-31
Last updated
2012-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Symptomatic Contact Lens Wearers

Keywords

Symptomatic, Contact lens care, Multi-purpose solution

Brief summary

The purpose of this study is to compare two contact lens care solutions in symptomatic wearers of silicone hydrogel contact lenses.

Interventions

Investigational multi-purpose disinfecting solution used by subjects as specified in use instructions provided for the care of study contact lenses, 30 days.

Commercially available multi-purpose solution used by subjects as indicated for care of study contact lenses, 30 days.

Contact lenses per subject's habitual brand and power worn for 30 days on a daily wear basis.

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Symptomatic silicone hydrogel contact lens wearers who wear their lenses daily wear (i.e., disinfect lenses every night). * Vision correctable to 20/30 or better with contact lenses. * Other protocol-defined inclusion criteria may apply.

Exclusion criteria

* Sensitivity to multi-purpose solutions. * Use of any topical ocular OTC or prescribed topical ocular medications. * History (6 months) or current ocular infections or ocular inflammatory events. * Ocular surgery within the past year. * Medical condition or use of medications that cause ocular side effects. * Participation in any investigational study within the past 30 days. * Other protocol-defined

Design outcomes

Primary

MeasureTime frameDescription
Likert Statement: When I Use This Solution, I Can Comfortably Wear my Lenses.Day 30As interpreted and reported by the subject on a questionnaire as a single, retrospective evaluation of the last three days of wearing experience. A 5-point Likert scale was used, where 1=strongly disagree, 2=disagree; 3=neither disagree nor agree; 4=agree; 5=strongly agree.

Secondary

MeasureTime frameDescription
Likert Statement: When I Use This Solution, My Lenses Are Comfortable From Morning Until Evening.Day 30As interpreted and reported by the subject on a questionnaire as a single, retrospective evaluation of the last three days of wearing experience. A 5-point Likert scale was used, where 1=strongly disagree, 2=disagree; 3=neither disagree nor agree; 4=agree; 5=strongly agree.
Likert Statement: When I Use This Solution, I Forget I am Wearing my Lenses.Day 30As interpreted and reported by the subject on a questionnaire as a single, retrospective evaluation of the last three days of wearing experience. A 5-point Likert scale was used, where 1=strongly disagree, 2=disagree; 3=neither disagree nor agree; 4=agree; 5=strongly agree.

Countries

United States

Participant flow

Recruitment details

Subjects were recruited and enrolled from 42 US study centers.

Pre-assignment details

The Participant Flow Chart includes all randomized patients: 591. Baseline characteristics are presented for all subjects who received test article and had at least one on-regimen study visit: 578.

Participants by arm

ArmCount
Alcon MPDS
Multi-purpose disinfecting contact lens solution
288
Renu Fresh MPS
Multi-purpose contact lens solution
290
Total578

Baseline characteristics

CharacteristicAlcon MPDSRenu Fresh MPSTotal
Age Continuous34.5 years
STANDARD_DEVIATION 11.43
34.0 years
STANDARD_DEVIATION 11.24
34.3 years
STANDARD_DEVIATION 11.33
Sex: Female, Male
Female
209 Participants212 Participants421 Participants
Sex: Female, Male
Male
79 Participants78 Participants157 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 2920 / 297
serious
Total, serious adverse events
1 / 2921 / 297

Outcome results

Primary

Likert Statement: When I Use This Solution, I Can Comfortably Wear my Lenses.

As interpreted and reported by the subject on a questionnaire as a single, retrospective evaluation of the last three days of wearing experience. A 5-point Likert scale was used, where 1=strongly disagree, 2=disagree; 3=neither disagree nor agree; 4=agree; 5=strongly agree.

Time frame: Day 30

Population: All enrolled and dispensed subjects with an on-regimen follow-up visit.

ArmMeasureValue (MEAN)Dispersion
Alcon MPDSLikert Statement: When I Use This Solution, I Can Comfortably Wear my Lenses.3.9 Units on a scaleStandard Deviation 0.92
Renu Fresh MPSLikert Statement: When I Use This Solution, I Can Comfortably Wear my Lenses.3.8 Units on a scaleStandard Deviation 1.05
Secondary

Likert Statement: When I Use This Solution, I Forget I am Wearing my Lenses.

As interpreted and reported by the subject on a questionnaire as a single, retrospective evaluation of the last three days of wearing experience. A 5-point Likert scale was used, where 1=strongly disagree, 2=disagree; 3=neither disagree nor agree; 4=agree; 5=strongly agree.

Time frame: Day 30

Population: All enrolled and dispensed subjects with an on-regimen follow-up visit.

ArmMeasureValue (MEAN)Dispersion
Alcon MPDSLikert Statement: When I Use This Solution, I Forget I am Wearing my Lenses.3.2 Units on a scaleStandard Deviation 1.13
Renu Fresh MPSLikert Statement: When I Use This Solution, I Forget I am Wearing my Lenses.3.1 Units on a scaleStandard Deviation 1.15
Secondary

Likert Statement: When I Use This Solution, My Lenses Are Comfortable From Morning Until Evening.

As interpreted and reported by the subject on a questionnaire as a single, retrospective evaluation of the last three days of wearing experience. A 5-point Likert scale was used, where 1=strongly disagree, 2=disagree; 3=neither disagree nor agree; 4=agree; 5=strongly agree.

Time frame: Day 30

Population: All enrolled and dispensed subjects with an on-regimen follow-up visit.

ArmMeasureValue (MEAN)Dispersion
Alcon MPDSLikert Statement: When I Use This Solution, My Lenses Are Comfortable From Morning Until Evening.3.3 Units on a scaleStandard Deviation 1.12
Renu Fresh MPSLikert Statement: When I Use This Solution, My Lenses Are Comfortable From Morning Until Evening.3.2 Units on a scaleStandard Deviation 1.21

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026